Presentation and management of insect bites in out-of-hours primary care: a descriptive study.
Clinical audit
Epidemiology
PRIMARY CARE
Journal
BMJ open
ISSN: 2044-6055
Titre abrégé: BMJ Open
Pays: England
ID NLM: 101552874
Informations de publication
Date de publication:
14 09 2023
14 09 2023
Historique:
medline:
18
9
2023
pubmed:
15
9
2023
entrez:
14
9
2023
Statut:
epublish
Résumé
To describe the population presenting to out-of-hours primary care with insect bites, establish their clinical management and the factors associated with antibiotic prescribing. An observational study using routinely collected data from a large out-of-hours database (BORD, Birmingham Out-of-hours general practice Research Database). A large out-of-hour primary care provider in the Midlands region of England. All patients presenting with insect bites between July 2013 and February 2020 were included comprising 5774 encounters. This cohort was described, and a random subcohort was created for more detailed analysis which established the clinical features of the presenting insect bites. Logistic regression was used to model variables associated with antibiotic prescribing. Of the 5641 encounters solely due to insect bites, 67.1% (95% CI 65.8% to 68.3%) were prescribed antibiotics. General practitioners were less likely to prescribe antibiotics than advanced nurse practitioners (60.5% vs 71.1%, p<0.001) and there was a decreasing trend in antibiotic prescribing as patient deprivation increased. Pain (OR 2.13, 95% CI 1.18 to 3.86), swelling (OR 2.88, 95% CI 1.52 to 5.46) and signs of spreading (OR 3.45, 95% CI 1.54 to 7.70) were associated with an increased frequency of antibiotic prescribing. Extrapolation of the findings give an estimated incidence of insect bite consultations in England of 1.5 million annually. Two-thirds of the patients presenting to out-of-hours primary care with insect bites receive antibiotics. While some predictors of prescribing have been found, more research is required to understand the optimal use of antibiotics for this common presentation.
Identifiants
pubmed: 37709307
pii: bmjopen-2022-070636
doi: 10.1136/bmjopen-2022-070636
pmc: PMC10503338
doi:
Substances chimiques
Anti-Bacterial Agents
0
Types de publication
Observational Study
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
e070636Informations de copyright
© Author(s) (or their employer(s)) 2023. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.
Déclaration de conflit d'intérêts
Competing interests: None declared.
Références
Diagnostics (Basel). 2020 May 15;10(5):
pubmed: 32429276
J Antimicrob Chemother. 2016 Jul;71(7):2037-46
pubmed: 27090629
BMC Fam Pract. 2016 Mar 31;17:38
pubmed: 27036116
J Antimicrob Chemother. 2019 Jan 1;74(1):242-250
pubmed: 30239809
Br J Gen Pract. 2010 Mar;60(572):e128-36
pubmed: 20202356
J Antimicrob Chemother. 2019 Aug 1;74(8):2440-2450
pubmed: 31038162
Drug Ther Bull. 2012 Apr;50(4):45-8
pubmed: 22495051
Fam Pract. 2006 Oct;23(5):490-6
pubmed: 16873392
Ther Adv Drug Saf. 2014 Dec;5(6):229-41
pubmed: 25436105
J Clin Epidemiol. 1996 Dec;49(12):1373-9
pubmed: 8970487
J Antimicrob Chemother. 2014 Mar;69(3):835-41
pubmed: 24176983
Malar J. 2021 Jan 18;20(1):44
pubmed: 33461560